Effectiveness and Safety of Pigment Solution Program (PSP) as Adjuvant Therapy in Melasma
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This research is a clinical study with a single-blind randomized clinical trial design (randomized controlled trial) in multicenters at two Dermatology and Venereology Education centers in Indonesia. This study aims to determine the effectiveness and safety of PSP as adjuvant therapy for melasma. This research will be attended by 33 research subjects
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 30
Maximum Age: 60
Healthy Volunteers: t
View:
• women aged 30-60 years
• Fitzpatrick skin phototype IV-V
• Diagnosis of epidermal, mixed and dermal types of Melasma
Locations
Other Locations
Indonesia
Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
RECRUITING
Jakarta Pusat
Contact Information
Primary
Prof. Dr. dr. Irma Bernadette S. Sitohang, SpKK(K) Sitohang
irma_bernadette@yahoo.com
+62818130761
Backup
dr. Lilik Norawati, SpKK Norawati
liliknora21@gmail.com
+628121107149
Time Frame
Start Date: 2023-09-25
Estimated Completion Date: 2023-12-31
Participants
Target number of participants: 33
Treatments
No_intervention: Group 1 (HQ group)
Group 1 is control group, getting SPF 30 sunscreen cream in the morning and only 2% Hydroquinone cream at night without a combination cream and facial soap that can be used in the morning and evening.
Experimental: Group 2 (PSP Group)
Group 2, the treatment group, used PSP cleanser, PSP Day Cream and SPF 30 sunscreen in the morning and used Hydroquinone 2% and PSP Night Cream at night and PSP cleanser which was used in the morning and evening before using the cream.
Related Therapeutic Areas
Sponsors
Collaborators: Menarini Group
Leads: Dr.dr.Irma Bernadette, SpKK (K)